This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Michael Murphy Craig in Tech-Bio Exploration
Introduction
Michael Murphy Craig is an innovative inventor based in Montreal, Canada. He has made significant contributions to the field of tech-bio exploration through his unique patent. His work focuses on utilizing language machine learning models to enhance the efficiency of computerized bio-activity discovery tools.
Latest Patents
Michael holds a patent for "Utilizing language machine learning models for autonomous executions of computerized tech-bio exploration tools." This patent describes systems, non-transitory computer-readable media, and methods for employing language machine learning models as autonomous reasoners. These systems are designed to navigate and execute multiple layers of a computerized bio-activity discovery pipeline. The technology allows users to provide tech-bio queries through an interactive prompt interface, enabling the LLM to execute tasks and generate bio-activity data efficiently.
Career Highlights
Michael is currently associated with Recursion Pharmaceuticals, Inc., where he applies his expertise in machine learning and bio-activity discovery. His innovative approach has positioned him as a key player in the tech-bio exploration sector. With a focus on enhancing the capabilities of bio-activity discovery tools, he continues to push the boundaries of what is possible in this field.
Collaborations
Michael has collaborated with notable colleagues, including Benjamin John Mabey and Caleb Ryan Phillips. Their combined efforts contribute to advancing the research and development of tech-bio exploration technologies.
Conclusion
Michael Murphy Craig's work exemplifies the intersection of technology and biology, showcasing the potential of language machine learning in revolutionizing bio-activity discovery. His contributions are paving the way for future innovations in the tech-bio exploration landscape.